<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02728986</url>
  </required_header>
  <id_info>
    <org_study_id>FR Study No-05-000001</org_study_id>
    <secondary_id>2014-A01128-39</secondary_id>
    <nct_id>NCT02728986</nct_id>
  </id_info>
  <brief_title>Cost Evaluation of Venous Leg Ulcers Management</brief_title>
  <acronym>EPIC</acronym>
  <official_title>Comparative and Prospective Evaluation of Direct Cost of Venous Leg Ulcers Management With Two Compression Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>3M</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate direct costs of Venous Leg Ulcers (VLU) management
      when two different compression systems are used.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate direct costs of Venous Leg Ulcers management when
      two different compression systems are used. Micro-costing during the study will bring direct
      costs which include nurse and physician time, dressings and bandages.

      Perspective of costs will be Public Health Insurance. Time horizon will be 16 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 17, 2015</start_date>
  <completion_date type="Actual">July 1, 2018</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Direct cost of leg ulcer management</measure>
    <time_frame>16 weeks</time_frame>
    <description>Direct cost includes cost of bandages, dressings, nurse/doctor visits. Cost will be computed upon consumptions reported by healthcare professionals.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of adverse events related to compression</measure>
    <time_frame>16 weeks</time_frame>
    <description>Number and type of adverse events related to compression bandages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's compression bandage acceptance score</measure>
    <time_frame>16 weeks</time_frame>
    <description>Four ad hoc 7-level Likert scales will be used to assess bandage impact on daily activities, sleep, shoes and slippage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with fully healed ulcer</measure>
    <time_frame>16 weeks</time_frame>
    <description>Full healing rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQoL 5D-5L change between baseline and last visit</measure>
    <time_frame>16 weeks</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average time to full healing</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">176</enrollment>
  <condition>Varicose Ulcer</condition>
  <arm_group>
    <arm_group_label>Compression1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multilayer compression bandage (Profore)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compression2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coban2 compression system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Profore</intervention_name>
    <description>Profore multilayer compression bandage + standard regimen for wound care according to investigator's choice</description>
    <arm_group_label>Compression1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coban2</intervention_name>
    <description>Coban2 compression system + standard regimen for wound care according to investigator's choice</description>
    <arm_group_label>Compression2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consent to participate

          -  ambulatory management

          -  1 to 3 leg ulcers

          -  leg ulcers below the knee and above ankle

          -  no contra-indication to wear compression bandage

          -  not currently treated by one of the investigational devices

        Exclusion Criteria:

          -  cognitive impairment

          -  opposition to wear compression bandage

          -  bedridden

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Meaume, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AP-HP HÃ´pital Rothschild - Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Quimper Center</name>
      <address>
        <city>Quimper</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>March 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2016</study_first_posted>
  <last_update_submitted>January 18, 2019</last_update_submitted>
  <last_update_submitted_qc>January 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Costs and Cost Analysis</keyword>
  <keyword>Humans</keyword>
  <keyword>Health Care Costs</keyword>
  <keyword>varicose ulcer</keyword>
  <keyword>Compression Bandages</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

